Literature DB >> 16195168

Palisaded neutrophilic granulomatous dermatitis presenting as an unusual skin manifestation in a patient with Behçet's disease.

S-K Kim1, C-K Park, Y-W Park, J-B Jun, D-H Yoo, S-C Bae.   

Abstract

A 32-year-old Korean woman with painful oral ulcers and a sore throat presented with multiple erythematosus papules on both legs. Histological examination of the papular lesions on the legs demonstrated palisaded granuloma with degeneration of collagen fibres in the dermis, compatible with palisaded neutrophilic granulomatous dermatitis (PNGD). This condition is known to be an unusual disease entity associated with various systemic autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, other connective tissue diseases, and systemic vasculitis. To our knowledge a case with typical Behçet's disease coinciding with PNGD among systemic autoimmune diseases has not been described before.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195168     DOI: 10.1080/03009740510015195

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  3 in total

1.  MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments.

Authors:  Heleen Scheerens; Zheng Su; Bryan Irving; Michael J Townsend; Yanan Zheng; Eric Stefanich; Vishala Chindalore; Clifton O Bingham; John C Davis
Journal:  Arthritis Res Ther       Date:  2011-10-26       Impact factor: 5.156

Review 2.  Palisaded Granulomatous Dermatitis Associated with Ulcerative Colitis: A Comprehensive Literature Review.

Authors:  Katherine M Stiff; Philip R Cohen
Journal:  Cureus       Date:  2017-01-06

3.  Palisaded Neutrophilic and Granulomatous Dermatitis in a Patient with Behçet's Disease: A Case Report.

Authors:  Young-Bin Shin; Jeong-Won Jo; Tae-Jin Yoon
Journal:  Ann Dermatol       Date:  2020-12-30       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.